Sedation and Congenital Cardiac CatheterizationLin, CH et al.
Supplemental Table 1A. Adverse Event Severity
Severity Level / DefinitionLow / 1 – None (very mild) / No harm, no change in condition,may have requiredmonitoring to assess forpotential change in condition with no intervention indicated.
2 – Minor / Transient change in condition, not life threatening, condition returns to baseline, required monitoring, required minor interventionsuch as holding a medication, or obtaining labtest.
High / 3 – Moderate / Transient change in conditionmay belife threateningif not treated, condition returns to baseline, required monitoring, required intervention such as reversal agent,additional medication,transfer to the intensive care unit for monitoring, or moderate trans-catheter intervention to correct condition.
4 – Major / Change in condition, life threatening if not treated, change in condition may be permanent, may have required an intensive care unit admission or emergent readmit to hospital, may have required invasive monitoring, required interventions such as electrical cardioversion or unanticipated intubation or required major invasive procedures or trans-catheter interventions to correct condition.
5 – Catastrophic / Any death, and emergent surgery or heart lung bypass support (ECMO) to prevent death with failure to wean from bypass support.
Supplemental Table 1B. Definitions of Hemodynamic Vulnerability
Non Single Ventricle / Single VentricleMixed Venous Saturation / < 60% / <50%
Systemic Ventricle End Diastolic Pressure / ≥ 18mmHg / ≥ 18mmHg
Systemic Arterial Saturation / <95% / <78%
Main Pulmonary Artery Pressure / Systolic ≥ 45mmHg / Mean ≥ 17mmHg
Supplemental Table 1C. Procedure Type Risk Categories
Risk Category 1 / Risk Category 2 / Risk Category 3 / Risk Category 4Diagnostic Case / Age ≥ 1 year / Age ≥ 1 month < 1year / Age < 1 month
Valvuloplasty / Pulmonary Valve ≥1 month / Aortic valve ≥ 1 month
Pulmonary valve < 1 month
Tricuspid valve / Mitral Valve
Aortic Valve < 1 month
Device or Coil Closure / Venous collateral
LSVC / PDA
ASD or PFO
Fontan Fenestration
Systemic to Pulmonary Artery collaterals / Systemic Surgical Shunt
Baffle Leak
Coronary Fistula / VSD
Perivalvar leak
Balloon Angioplasty / RVOT
Aorta dilation < 8 ATM / Pulmonary artery < 4 vessels
Pulmonary artery ≥ 4 vessels all < 8 ATM
Aorta > 8 ATM or CB
Systemic Artery (not aorta)
Systemic Surgical Shunt
Systemic to Pulmonary Collaterals
Systemic vein / Pulmonary Artery ≥ 4 vessels
Pulmonary vein
Stent Placement / Systemic vein / RVOT
Aorta
Systemic artery (not aorta) / Ventricular septum
Pulmonary artery
Pulmonary vein
Systemic Surgical Shunt
Systemic pulmonary Collateral
Stent Redilation / RVOT
Atrial Septum
Aorta
Systemic Artery (not Aorta)
Systemic vein / Pulmonary Artery
Pulmonary vein / Ventricular septum
Other / Myocardial Biopsy / Snare foreign body
Trans-septal puncture / Atrial septostomy
Recanalization of Jailed Vessel in Stent
Recanalization of Occluded Vessel / Atrial Septum Dilation and Stent
Any Catheterization < 4 days after Surgery
Atretic valve perforation
Page | 1
Sedation and Congenital Cardiac CatheterizationLin, CH et al.
Supplemental Table2.Number of Sedation and Airway Related Adverse Events Summarized by Severity
Adverse Event Severity LevelSedation or Airway Adverse Event / 1 / 2 / 3 / 4 / 5
Anesthesia Problem / 1 / 11 / 7 / 0 / 0
Airway Obstruction / 0 / 11 / 7 / 2 / 0
Apnea / 0 / 8 / 7 / 1 / 0
Aspiration / 0 / 0 / 1 / 0 / 0
Bleeding via ETT / 2 / 4 / 6 / 0 / 0
Hypotension / 2 / 74 / 12 / 5 / 0
Hypoxia / 0 / 8 / 9 / 1 / 0
Laryngospasm / 0 / 1 / 4 / 2 / 0
Post Extubation Stridor / 0 / 2 / 3 / 0 / 0
Respiratory Acidosis PaCO2 >45 / 1 / 10 / 6 / 0 / 0
Respiratory Arrest / 0 / 0 / 1 / 3 / 2
Respiratory Distress / 0 / 2 / 4 / 2 / 0
Unplanned Extubation / 0 / 4 / 2 / 1 / 0
Other Sedation or Airway Problem / 5 / 12 / 4 / 2 / 0
Page | 1
Sedation and Congenital Cardiac CatheterizationLin, CH et al.
Supplemental Table 3. CHARM-Adjusted Multivariable Analysis
Odds Ratio(95% CI) / P Value
Artificial Airway / 1.8 (1.4, 2.3) / <0.001
Procedure Type Risk Category
1 / 1.0
2 / 2.2 (1.6, 2.9) / <0.001
3 / 4.4 (3.3, 5.8) / <0.001
4 / 5.8 (4.3, 7.8) / <0.001
Number of Hemodynamic Indicators
0 / 1.0
1 / 1.4 (1.1, 1.7) / 0.002
2+ / 1.9 (1.5, 2.4) / <0.001
Age < 1 year / 1.2 (1.0, 1.5) / 0.07
Supplemental Table 4.Propensity score-adjusted analysis, outcome any high severity adverse event
Odds Ratio(95% CI) / P Value
Artificial Airway / 1.7 (1.4, 2.1) / <0.001
Propensity Score Quintile
1 / 1.0
2 / 1.6 (1.1, 2.4) / 0.006
3 / 1.9 (1.3, 2.8) / <0.001
4 / 2.7 (1.9, 3.8) / <0.001
5 / 5.3 (3.8, 7.4) / <0.001
Page | 1